Ovarian cancer drug approved for NHS use will prolong lives
More than 7,500 women are diagnosed with ovarian cancer every year. LADYMAYPIX/ Shutterstock A drug that can treat chemotherapy-resistant ovarian cancer has just been approved for use on the NHS in England. Mirvetuximab soravtansine (also known as Elahere) is the first new drug to be approved for hard-to-treat ovarian cancer in over 20 years. In […]
Continue Reading
